ExodusPoint Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.48M Buy
34,260
+7,861
+30% +$566K 0.01% 807
2026
Q2
$1.87M Buy
+26,399
New +$1.43M 0.01% 847
2026
Q1
– Sell
-223,061
Closed -$13.1M – 2084
2025
Q4
$13.1M Buy
+223,061
New +$13.6M 0.1% 188
2024
Q1
– Sell
-126,506
Closed -$9.8M – 1953
2023
Q4
$9.8M Buy
126,506
+72,289
+133% +$4.76M 0.06% 208
2023
Q3
$3.69M Buy
+54,217
New +$4.28M 0.04% 456
2023
Q2
– Sell
-65,965
Closed -$4.89M – 2240
2023
Q1
$4.89M Buy
+65,965
New +$5.08M 0.04% 525
2022
Q4
– Sell
-39,352
Closed -$2.79M – 2121
2022
Q3
$2.79M Buy
+39,352
New +$3.4M 0.04% 627
2021
Q4
– Sell
-21,880
Closed -$2.65M – 2584
2021
Q3
$2.65M Buy
21,880
+18,444
+537% +$2.24M 0.04% 613
2021
Q2
$387K Sell
3,436
-293,308
-99% -$30.9M ﹤0.01% 1582
2021
Q1
$28.3M Buy
296,744
+282,748
+2,020% +$25.8M 0.41% 25
2020
Q4
$1.11M Buy
13,996
+6,624
+90% +$480K 0.01% 798
2020
Q3
$457K Sell
7,372
-4,592
-38% -$299K 0.01% 1065
2020
Q2
$790K Buy
+11,964
New +$716K 0.02% 861
2019
Q3
– Sell
-4,136
Closed -$216K – 1639
2019
Q2
$216K Sell
4,136
-13,908
-77% -$701K 0.01% 887
2019
Q1
$896K Buy
+18,044
New +$812K 0.07% 207

Other funds holding TECH

ExodusPoint Capital Management's TECH Position: Q3 2026 in Review

ExodusPoint Capital Management increased its Bio-Techne (TECH) stake by 30% in Q3 2026, buying an estimated $566K and bringing the position to 34,260 shares worth $2.48M. The position accounts for 0.01% of the portfolio, ranked #807.

ExodusPoint Capital Management first reported a position in TECH in Q1 2019 and has held it in 15 quarters since. The position peaked at $28.3M in Q1 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • ExodusPoint Capital Management held 34,260 shares of Bio-Techne worth $2.48M as of Q3 2026.
  • ExodusPoint Capital Management bought 7,861 Bio-Techne shares in Q3 2026, an estimated $566K.
  • Bio-Techne made up 0.01% of ExodusPoint Capital Management's portfolio in Q3 2026, its #807 holding.
  • ExodusPoint Capital Management first reported a position in Bio-Techne in Q1 2019 and has held it in 15 quarters since.
  • ExodusPoint Capital Management's Bio-Techne position peaked at $28.3M in Q1 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.